LPC: Valeant refinancing on track despite Ackman stock sale

NEW YORK (Reuters) - Drugmaker Valeant Pharmaceuticals will not see any changes to its planned refinancing in the wake of billionaire William Ackman and his hedge fund Pershing Square selling its share of the company, sources said.

LPC: Valeant refinancing on track despite Ackman stock sale
Read More


Bagikan Berita Ini